Richard Marshak - 24 Jan 2024 Form 4 Insider Report for TriSalus Life Sciences, Inc. (TLSI)

Role
SR.VP, CORP. DEV. & STRATEGY
Signature
/s/ Sean Murphy, Attorney-in-Fact
Issuer symbol
TLSI
Transactions as of
24 Jan 2024
Transactions value $
$0
Form type
4
Date filed
25 Jan 2024, 17:43
Previous filing
14 Aug 2023
Next filing
14 Feb 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TLSI Employee Stock Option (right to buy) Award $0 +40K $0.00 40K 24 Jan 2024 Common Stock 40K $9.28 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-fourth (1/4th) of the shares subject to the option shall vest on the one-year anniversary of the Vesting Commencement Date of January 24, 2024, and 1/36th of the remaining shares shall vest each month thereafter, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.